The mission of the ACTG Network is to reduce the burden of disease
due to HIV, tuberculosis, and viral hepatitis.
History of the ACTG
Organizational Matrix (PDF - 65 KB)
State of the ACTG (PDF - 324 KB)
Bylaws, SOPs, and Guidelines
Templates and Forms
Annual Progress Reports
Performance Evaluation Program
Leadership and Operations Center
Network Coordinating Center
Statistical and Data Management Center
Glossary of HIV-Related Terms (DOC - 326 KB)
Surveillance Case Definitions for HIV
Glossary of General Abbreviations and Acronyms (DOC - 115 KB)
ACTG Acronyms, Abbreviations, and Codes (PDF - 29 KB)
IRIS Case Definitions
About the Trial Process
About Clinical Trials
Comments from a Trial Participant
Trials Open to Enrollment
Layman’s Study Summaries
Access to Published Data
Clinical Trials Resources
Leadership Steering Committee
Scientific Agenda Steering Committee
Data Management Committee
Performance Evaluation Committee
Underrepresented Populations Committee
End-organ Disease and Inflammation
Co-infections and Malignancies Subcommittee
Antiretroviral Strategies Subcommittee
HIV Reservoirs and Viral Eradication
Global Community Advisory Board
Site Management & Clinical Care
Global Community Advisory Boards
History of Community Participation in the ACTG
Additional Handbook Material
Community Scientific Subcommittee
HIV in the News
ACTG in Social Media
You are here
HIV in the News
Women in Failed PrEP Trial Lied About Pill Use to Stay In Study
April 24, 2015
Female participants in a failed study of Truvada as pre-exposure prophylaxis (PrEP) often lied about their pill use in order to remain in the study.
ARVs Cut HIV Transmission Risk By 67% in Chinese Real-World Study
April 23, 2015
A Chinese study of the real-world effects of antiretroviral treatment's capacity to reduce the risk of HIV transmission has found it halves the risk, and in more recent years treatment led to a two-thirds risk reduction.
HIV Ages Immune Cell DNA by 14 Years
April 22, 2015
Untreated HIV causes changes to cellular DNA that are akin to 14 years of aging, which may partially explain the early onset of age-related diseases among people living with the virus.
European Liver Group Issues New Hep C Treatment Guidelines
April 22, 2015
The European Association for the Study of the Liver has issued revised guidelines for the treatment of hepatitis C.
HIV Researcher Questions Prevailing Wisdom About the Virus
April 21, 2015
A major HIV researcher has challenged colleagues to question various perceptions about the virus and its treatment in hopes of spurring new research channels.
Good Mental Health Likely Means Good Adherence to HIV Meds
April 20, 2015
Psychological wellbeing emerged as the only factor that predicted good adherence to HIV antiretrovirals in a recent study.
HIV Antibody Infusion Shows Promise in Treating The Virus
April 17, 2015
A single infusion of a broadly neutralizing HIV antibody has reduced viral loads for up to four weeks among HIV-positive individuals.
Intervention Improves HIV Med Adherence Among Blacks and Latinos
April 16, 2015
A counseling-based intervention has succeeded in improving adherence to antiretrovirals among HIV-positive blacks and Latinos who are reluctant to start treatment.
Poll of HIV Providers Finds Some Reluctance Toward PrEP Prescribing
April 15, 2015
Statins May Cut Heart Disease Risk in HIV-Positive People
April 14, 2015
Research increasingly suggests that statins can prevent the advancement of coronary atherosclerosis among HIV-positive people.